跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
欣普尼 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Golimumab Injection
Approved
生物制品
Golimumab Injection
Janssen Biologics BV
🇨🇳 National Medical Products Administration
Approval Date
Dec 17, 2019
Approval ID
7MaoUHjDTjZ
Company
Janssen Biologics BV
Type
生物制品
Approval Details
Approval Id
7MaoUHjDTjZ
Approval Number
S20170050
Generic Name
戈利木单抗注射液
Generic Name En
Golimumab Injection
Trade Name
欣普尼
Brand Name
欣普尼
Drug Type
生物制品
Dosage Form
注射剂
Strength
50mg/0.5ml/支
Reg Date
2019-12-17
Expired Date
2024-12-16
Company Name
Janssen Biologics BV
Company Address
Einsteinweg 101, 2333 CB Leiden, The Netherlands
Production Company Name
Cilag AG
Production Company Address
Hochstrasse 201, CH-8200 Schaffhausen, Switzerland
Company Detail Path
/organization/janssen-biologics-bv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 17, 2019
Approval ID
7MaoUHjDTjZ
Type
生物制品
Back to NMPA Approvals